SEC Form 4 · accession 0001144204-15-020558
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick G Enright
Director · 10% Owner
Period of report
Mar 30, 2015
Accepted (ET)
Apr 1, 2015 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 30, 2015 | X | 839,811 | $4.05 | A | 14,516,932 | I | By LVP |
| Common StockF3 | Mar 30, 2015 | X | 16,833 | $4.05 | A | 194,958 | I | By LCA |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (Right to Buy)F1 | $4.05 | Mar 30, 2015 | X | 839,811 | D | Mar 29, 2012 | Mar 30, 2015 | Common Stock | 839,811 | 0 | I |
| Warrant (Right to Buy)F3 | $4.05 | Mar 30, 2015 | X | 16,833 | D | Mar 29, 2012 | Mar 30, 2015 | Common Stock | 16,833 | 0 | I |
Explanation of responses
- F1Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP"). Patrick G. Enright is a managing member of Longitude Capital Partners, LLC ("Longitude Capital"), the sole general partner of LVP. Mr. Enright serves on the Board of Directors of the Issuer as the nominee of LVP. Mr. Enright disclaims beneficial ownership of the securities of the Issuer held of record by LVP, except to the extent of his pecuniary interest therein.
- F2On March 30, 2015, LVP exercised a warrant to purchase 839,811 shares of the Issuer's common stock for a cash exercise price of $4.05 per share.
- F3Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. ("LCA"). Patrick G. Enright is a managing member of Longitude Capital, the sole general partner of LCA. Mr. Enright disclaims beneficial ownership of the securities of the Issuer held of record by LCA, except to the extent of his pecuniary interest therein.
- F4On March 30, 2015, LCA exercised a warrant to purchase 16,833 shares of the Issuer's common stock for a cash exercise price of $4.05 per share.